The world suffering from the corona virus epidemic is currently awaiting the most vaccines. In many countries of the world, including India, many vaccines are working day and night. Many vaccines who have reached the advanced stage are hoping that in a few months, people will get a weapon to protect themselves from this deadly virus. But this does not end with the development of the vaccine. Vaccine access to all people around the world, especially in poor and developing countries, is no less a big challenge.
From the factory to the syringes, almost all possible corona vaccines in the world will require non-stop refridgeration to remain safe and effective. But 3 billion people out of the world’s 7.8 billion population live in places where there is not enough cold storage for vaccines. This means that the poor most affected by the pandemic around the world will be able to be protected for a long time.
The vaccine cold chain barrier is the latest epidemic inequality for the poor, who often work in congested areas, allowing the virus to spread. Access to medical oxygen is low and the medical system lacks labs and testing. Creating cold chains for the corona virus vaccine will not be easy for even the richest countries, especially for those vaccines that require ultracold storage of -70 ° C.
Investments in infrastructure and cooling technology are lagging behind vaccine development that began this year due to the virus. The epidemic has been 8 months and logistics experts are warning that there is a lack of refridgeration in most parts of the world for effective vaccination. Most of these countries include Central Asia, India and South Asia, Latin America and many corners of Africa.
International organizations have arranged thousands of solar-powered vaccine refrigerators to form cold chains in developing countries. Considering the need for stable temperatures from vaccine production to vaccination, mobile refrigeration, dormant electricity, good roads and most importantly advance planning are needed. For poor countries like Burkina Faso, the best chance of getting a vaccine is with Kovacs, an initiative of the World Health Organization. Its goal is distribution in poor countries by placing an order for a good vaccine.
UNICEF started ground work in Copenhagen months ago for global distribution. The warehouse, looking at the past experience of the world’s largest humanitarian aid, is trying to address the shortage of logistics staff, particularly as the outbreak of the worldwide epidemic brought masks and PPE kits and its From theft to black marketing.
According to the World Health Organization, 42 corona virus vaccine candidates are currently undergoing trials, while 151 are in the pre-clinical stage. The vaccine most likely to succeed in Kovacs needs to be stored at a temperature of 2 to 8 degrees Celsius. The Pfizer vaccine arrived at advance testing will need to be stored in the ultracold temperature. The company, which also produces a special box for the vaccine, has shown interest in Kovacs and has signed contracts with the US, Europe and Japan.
Medical freezers that require a temperature of minus 70 degrees are also rare in hospitals in the US and Europe. Many experts believe that West African countries are in a good position in this case, where there was an outbreak of Ebola in 2014–16, because the vaccine against this virus required B. ultracold storage. It is estimated that 15,000 cargo flights would be required to deliver the Kovid-19 vaccine worldwide.
